Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Medtronic, Inc. announced the start of a nationwide trial to examine the relationship between the company's OptiVol Fluid Status Monitoring technology and the ability to predict worsening heart failure, a leading cause of hospitalizations worldwide. The trial will assess whether more frequent review of patient data results in earlier clinical intervention.

Today in Drug Trials...keeping you current

The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09

Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09

Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09

Today in Medical Devices/Products...keeping you current

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09

Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09

Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address